Literature DB >> 17280755

HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design.

Inna G Ovsyannikova1, Robert M Jacobson, Robert A Vierkant, V Shane Pankratz, Gregory A Poland.   

Abstract

Although the outcome of the immune response to measles-mumps-rubella (MMR) vaccination depends on multiple factors, elucidation of specific host genetic markers, such as HLA supertypes based on a shared sequence motif in the peptide-binding pockets of HLA molecules, is essential. We studied the association between measures of humoral and cellular immune responses and HLA supertypes among 346 children previously immunized with two doses of MMR. We found that HLA supertypes, such as A3, B7, B44, B58, B62, and DR may play a role in modulating immune responses to the measles and mumps components of MMR vaccine. This information may be of significant value in the engineering of potential epitope-based vaccines that are recognized by T cells restricted by human HLA supertype alleles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17280755     DOI: 10.1016/j.vaccine.2007.01.020

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  31 in total

1.  Consistency of HLA associations between two independent measles vaccine cohorts: a replication study.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2012-01-25       Impact factor: 3.641

Review 2.  Vaccinology in the genome era.

Authors:  C Daniela Rinaudo; John L Telford; Rino Rappuoli; Kate L Seib
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

Review 3.  Vaccinomics: current findings, challenges and novel approaches for vaccine development.

Authors:  Inna G Ovsyannikova; Gregory A Poland
Journal:  AAPS J       Date:  2011-06-14       Impact factor: 4.009

Review 4.  Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Richard B Kennedy; Iana H Haralambieva; Robert M Jacobson
Journal:  OMICS       Date:  2011-07-06

5.  Vaccines, reverse vaccinology, and bacterial pathogenesis.

Authors:  Isabel Delany; Rino Rappuoli; Kate L Seib
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

6.  Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Megan M O'Byrne; Robert M Jacobson; V Shane Pankratz; Gregory A Poland
Journal:  Vaccine       Date:  2012-01-20       Impact factor: 3.641

Review 7.  Systems biology approaches to new vaccine development.

Authors:  Ann L Oberg; Richard B Kennedy; Peter Li; Inna G Ovsyannikova; Gregory A Poland
Journal:  Curr Opin Immunol       Date:  2011-05-11       Impact factor: 7.486

8.  HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial.

Authors:  K M Baldwin; P K Ehrenberg; A Geretz; H A Prentice; S Nitayaphan; S Rerks-Ngarm; J Kaewkungwal; P Pitisuttithum; R J O'Connell; J H Kim; R Thomas
Journal:  Tissue Antigens       Date:  2015-02

Review 9.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

10.  Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Neelam Dhiman; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.